CTOs on the Move

EndoChoice

www.endochoice.com

 
EndoChoice Based in Atlanta GA, EndoChoice® is a medtech company focused on the manufacturing and commercialization of platform technologies including devices, diagnostics, infection control and endoscopic imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice leverages its direct sales organization to serve more than 2,000 customers in the United States and works with 34 distribution partners world-wide. The Company was founded in 2008 and has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy® System (Fuse®). 2014 marked the fifth consecutive year EndoChoice was recognized as one of the fastest growing companies in the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

EndoChoice raised $96M on 06/06/2015

Similar Companies

Providence Clinical Research

Providence Clinical Research is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LED DENTAL INC

LED DENTAL INC is a White Rock, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.

Remington Medical Inc

Remington Medical Inc is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oraya Therapeutics

Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye. The company is currently testing its first application of the IRay stereotactic radiotherapy system.